Back to Search
Start Over
ONE YEAR FOLLOW-UP RESULTS FROM PRESERVE-AMI: A RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED CLINICAL TRIAL OF INTRACORONARY INFUSION OF AUTOLOGOUS CD34+ CELLS IN PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION POST STEMI
- Source :
- Journal of the American College of Cardiology. 65:A1593
- Publication Year :
- 2015
- Publisher :
- Elsevier BV, 2015.
-
Abstract
- ST segment Elevation Myocardial Infarction (STEMI) affects 160,000 annually in the US. Guidelines direct immediate revascularization and adjunctive medical therapies. Yet STEMI victims remain at risk for infarct expansion, heart failure, reinfarction, repeat revascularization and death. In pre
- Subjects :
- medicine.medical_specialty
One year follow up
business.industry
medicine.medical_treatment
medicine.disease
Revascularization
Placebo
Surgery
Clinical trial
Double blind
surgical procedures, operative
Heart failure
Internal medicine
medicine
Cardiology
ST segment
cardiovascular diseases
Myocardial infarction
Cardiology and Cardiovascular Medicine
business
Subjects
Details
- ISSN :
- 07351097
- Volume :
- 65
- Database :
- OpenAIRE
- Journal :
- Journal of the American College of Cardiology
- Accession number :
- edsair.doi.dedup.....9fa00743390b2106d8731d02a7528705
- Full Text :
- https://doi.org/10.1016/s0735-1097(15)61593-5